Skvortsova said the results of the researches cures for coronavirus
The head of the Federal medical-biological Agency (FMBA) Veronika Skvortsova on the online press-conference told about the results of preclinical studies of the drug "Mefloquine" for the treatment of coronavirus.
it turned out that he "suppresses 100 % cytopathic effect of the virus within 48 hours from the time of infection, but in a very small dose of two micrograms per milliliter," said the head of the Department.
If the drug is used to infection, then the virus is reduced by 50-75 %, she added. So, " Mefloquine ", maybe can use for prevention.
according to her, by the end of the first week "Mefloquine" 70% of patients are guaranteed to get rid of the virus.
While 26 % of the patients, the drug causes side effects, and among them a feeling of stoppage in the heart and sleep disorders.
Skvortsova said that the phenomenon is not difficult tolerated, but they exist, for this reason, When choosing a drug for treatment it is necessary to take into account the condition of the heart and intracardiac conduction.
in Russia since the beginning of the epidemic have recorded 262 843 patients COVID-19, more than 58 thousand recovered, 2418 patients died.
Current information on the situation of COVID-19 in Russia and the world presented on the portal stopmanager. Of the Russian Federation.
<span style="color:darkgray
|
